Not bad.
Still concerned that the international partnerships are not generating revenue and I'll need to check, but it appears some have been pushed another quarter.
- $3M for the quarter which includes $1.3M in Government rebates
- 1.7M customers
- $40k for Q4 to Jim Xenos (I assume)
HMS (US)
- international green shoots from initial revenues in US (how much is a green shoot?)
- First US health program went live through the Adheris partnership late in Q4 (where is the milestone payment?)
Zuellig (Asia)
- go live towards the end of Q2 FY21
Day Lewis (UK)
- go live Q1 FY21
- go live Q2 FY21
Ann: MedAdvisor June 2020 Quarterly Activities Report, page-2
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.0¢ |
Change
-0.010(1.82%) |
Mkt cap ! $297.2M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 54.5¢ | 51.0¢ | $105.8K | 202.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3780 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 9069 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MDR (ASX) Chart |